Early Post-Operative Endoscopy Is Associated with Lower Surgical Recurrence of Crohn's Disease: A Retrospective Study of Three Successive Cohorts

Overview

Journal Gastroenterol Res Pract

Publisher Wiley

Specialty Gastroenterology

Date 2022 Nov 17

PMID 36388633

Authors

Caroline Amicone

Carla Coimbra Marques

Catherine Reenaers

Catherine Van Kemseke

Laurence Seidel

Edouard Louis

Affiliations

Soon will be listed here.

Abstract

Background: The severity of endoscopic recurrence during the first year after intestinal resection for Crohn's disease is predictive of clinical recurrence. The aim of our study was to assess the impact of the implementation of an ileocolonoscopy during the first year after surgery on surgical recurrence.

Methods: All patients who underwent a first intestinal resection for Crohn's disease between 1992 and 2018 at the University Hospital of Liège were retrospectively included. The time to surgical recurrence was compared in three successive groups of patients operated on in the period 1992-2001 (group A), 2002-2011 (group B), and 2012-2020 (group C) using the Kaplan-Meier method and the Log-Rank test. To identify independent prognostic factors, a multivariate analysis was used via the Cox model.

Results: 223 patients (group A = 69, group B = 94, group C = 60) were included. Probabilities of surgical recurrence were significantly lower in group C (2.2% and 4.7% at 3 and 5 years, respectively) compared with group B (4.2% and 7.6% at 3 and 5 years, respectively) and with group A (9% and 18.2% at 3 and 5 years, respectively) ( = 0.0089). Ileocolonoscopy during the year after surgery was associated with a significantly reduced surgical recurrence rate in univariate and multivariate analysis (HR = 0.31, = 0.0049).

Conclusion: The implementation of an early ileocolonoscopy after surgery for Crohn's disease since early 2000 has been associated with a reduced surgical recurrence over the last 30 years.

References

Colombel J, Rutgeerts P, Malchow H, Jacyna M, Nielsen O, Rask-Madsen J . Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut. 2001; 49(1):42-6. PMC: 1728363. DOI: 10.1136/gut.49.1.42. View

Barnes E, Lightner A, Regueiro M . Perioperative and Postoperative Management of Patients With Crohn's Disease and Ulcerative Colitis. Clin Gastroenterol Hepatol. 2019; 18(6):1356-1366. DOI: 10.1016/j.cgh.2019.09.040. View

Peyrin-Biroulet L, Loftus Jr E, Colombel J, Sandborn W . The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol. 2009; 105(2):289-97. DOI: 10.1038/ajg.2009.579. View

Olivera P, Spinelli A, Gower-Rousseau C, Danese S, Peyrin-Biroulet L . Surgical rates in the era of biological therapy: up, down or unchanged?. Curr Opin Gastroenterol. 2017; 33(4):246-253. DOI: 10.1097/MOG.0000000000000361. View

De Cruz P, Kamm M, Hamilton A, Ritchie K, Krejany E, Gorelik A . Crohn's disease management after intestinal resection: a randomised trial. Lancet. 2014; 385(9976):1406-17. DOI: 10.1016/S0140-6736(14)61908-5. View

Candia R, Bravo-Soto G, Monrroy H, Hernandez C, Nguyen G . Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease. Cochrane Database Syst Rev. 2020; 8:CD012328. PMC: 8094885. DOI: 10.1002/14651858.CD012328.pub2. View

Collins M, Sarter H, Gower-Rousseau C, Koriche D, Libier L, Nachury M . Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence. J Crohns Colitis. 2016; 11(3):281-288. DOI: 10.1093/ecco-jcc/jjw151. View

De Cruz P, Kamm M, Hamilton A, Ritchie K, Krejany E, Gorelik A . Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis. Aliment Pharmacol Ther. 2015; 42(7):867-79. DOI: 10.1111/apt.13353. View

Lopez-Sanroman A, Vera-Mendoza I, Domenech E, Taxonera C, Vega Ruiz V, Marin-Jimenez I . Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial. J Crohns Colitis. 2017; 11(11):1293-1301. DOI: 10.1093/ecco-jcc/jjx051. View

10.

King D, Coupland B, Dosanjh A, Cole A, Adderley N, Reulen R . The risk of later surgery at the anastomotic site following right hemicolectomy for Crohn's disease in a national cohort of 12 230 patients. Aliment Pharmacol Ther. 2020; 53(1):114-127. DOI: 10.1111/apt.16114. View

11.

Swoger J, Regueiro M . Preventive therapy in postoperative Crohn's disease. Curr Opin Gastroenterol. 2010; 26(4):337-43. DOI: 10.1097/MOG.0b013e328338f724. View

12.

Freeman H . Long-term natural history of Crohn's disease. World J Gastroenterol. 2009; 15(11):1315-8. PMC: 2658833. DOI: 10.3748/wjg.15.1315. View

13.

Rutgeerts P, Geboes K, VANTRAPPEN G, KERREMANS R, Coenegrachts J, Coremans G . Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut. 1984; 25(6):665-72. PMC: 1432363. DOI: 10.1136/gut.25.6.665. View

14.

Gionchetti P, Dignass A, Danese S, Magro Dias F, Rogler G, Lakatos P . 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. J Crohns Colitis. 2016; 11(2):135-149. DOI: 10.1093/ecco-jcc/jjw169. View

15.

Van Assche G, Dignass A, Reinisch W, van der Woude C, Sturm A, De Vos M . The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis. 2010; 4(1):63-101. DOI: 10.1016/j.crohns.2009.09.009. View

16.

Lochs H, Mayer M, Fleig W, Mortensen P, Bauer P, Genser D . Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology. 2000; 118(2):264-73. DOI: 10.1016/s0016-5085(00)70208-3. View

17.

Yamamoto T . Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol. 2005; 11(26):3971-9. PMC: 4502089. DOI: 10.3748/wjg.v11.i26.3971. View

18.

Yamamoto T, Umegae S, Matsumoto K . Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study. Inflamm Bowel Dis. 2009; 15(10):1460-6. DOI: 10.1002/ibd.20915. View

19.

Bemelman W, Warusavitarne J, Sampietro G, Serclova Z, Zmora O, Luglio G . ECCO-ESCP Consensus on Surgery for Crohn's Disease. J Crohns Colitis. 2017; 12(1):1-16. DOI: 10.1093/ecco-jcc/jjx061. View

20.

Regueiro M, Kip K, Baidoo L, Swoger J, Schraut W . Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence. Clin Gastroenterol Hepatol. 2014; 12(9):1494-502.e1. DOI: 10.1016/j.cgh.2013.12.035. View